• Repurpose or Innovate: Sustained release changes everything

    TheraKine is partnering with global biopharmaceutical companies

  • Take control  with sustained release injectable formulations

    TheraKine is partnering with global biopharmaceutical companies

  • Life cycle management with significant performance advantages

    TheraKine is partnering with global biopharmaceutical companies

  • Organ-specific formulations? We do that!

    TheraKine is partnering with global biopharmaceutical companies

  • Local sustained delivery for your drug

    TheraKine is partnering with global biopharmaceutical companies

  • Become BIOBETTER with TheraKine

    TheraKine is partnering with global biopharmaceutical companies

TheraKine Limited is a privately held drug delivery Company

PressCONTACT US

Therakine Announces New Chief Executive Officer, December 10, 2016 10:47:35 December 9, 2016

Therakine Patent Portfolio for Sustained Release Of Injectable Drugs, November 16, 2016 08:31:23 November 4, 2016

TheraKine Receives Patent for Formulation Method that Enables Sustained Release of Injectable Drugs, October 14, 2016 08:56:09 BioCorRx

BioCorRx Announces License Agreement with TheraKine Ltd. to Develop New Injectable Naltrexone Technology, October 14, 2016 08:53:13 BioCorRx

Aldershof Special 41 Publication on Analytic City - see Page 11. June 2015. Expertise from across the street. , June 22, 2015 09:15:18 TheraKine's R&D Facilities

Additional Patents, August 28, 2014 21:34:01 Therakine, Ltd. Files Additional Patents

BioPartnering, August 28, 2014 21:31:08 RBCC and Therakine Initiate Phase II of Drug Delivery Development

Ernst-Günter Afting, Ph.D, Chairman of the Board, August 28, 2014 21:29:25 Therakine, Ltd. Appoints Ernst-Günter Afting, Ph.D, Chairman of the Board

Fierce Drug Delivery, October 16, 2013 00:00:00 TheraKine's Delivery Matrix Offers Long-Term Opioid Dependence Results